Clinical Trials Browser

Phase 3 × Completed × Non-Muscle Invasive Bladder Neoplasms × Clear all

NCT05136898 2024-09-19

Feasibility of Home Instillation of UGN-102 for Treatment of Low-Grade (LG) Non-Muscle Invasive Bladder Cancer (NMIBC)

Phase 3 Completed

8 enrolled 18 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT02773849 2024-07-29

ADSTILADRIN (=INSTILADRIN) in Patients With High-Grade, Bacillus Calmette-Guerin (BCG) Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)

Phase 3 Completed

157 enrolled 22 charts 1 FDA

Non-Muscle Invasive Bladder Neoplasms

NCT02449239 2023-07-24

VISTA

Phase 3 Completed

133 enrolled 18 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02695771 2023-04-21

BIC

Phase 3 Completed

101 enrolled 11 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02560584 2018-07-02

A Study of Blue Light Flexible Cystoscopy With Cysview in the Detection of Bladder Cancer in the Surveillance Setting

Phase 3 Completed

304 enrolled 11 charts

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT01149174 2011-10-04

EMDA/PRE-TUR

Phase 3 Completed

Non-Muscle Invasive Bladder Neoplasms